Medicines, 2019
Shortlist up to four to read them side by side.
2,152 medicine recalls FDA’s Enforcement Report published in 2019, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 7, 2026.
2,152of 2,152 medicine recallsshown with your filters
The list
- Medicine recall Ascorbic Acid, Compounded-Tapioca, 450 mg/mL Injection, 50 mL Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Thymosin Beta-4, 15 mg Injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sermorelin Theanine/GHRP2, 15 mg/75 mg/5.4 mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sermorelin 9 mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sermorelin/GHRP2/GHRP6, 9 mg/9 mg/9 mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sermorelin/GHRP2/GHRP6 6mg/3mg/3mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ipamorelin+Modified GRF 1-29, 9 mg/5mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ipamorelin, 9 mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ipamorelin+Sermorelin, 15mg/15mg, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ipamorelin, 15mg, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall IGF-1 LR3, 620 mcg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Epithalon, 15mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Bremelanotide (PT 141), 20mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BPC 157, 10mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HCG, Human chorionic gonadotropin 11,000 units, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HCG, Human chorionic gonadotropin 5,000 units, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HCG, Human chorionic gonadotropin 2,000 units, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sermorelin, 15mg, injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall IGF-1-LR3, 3 mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Melanotan II, 10mg injection Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall ICB-Complex, injection,Inositol/Choline/B1/B2/B3/B5/B6/B12/Leucine/Carnitine/Chromium/Lidocaine:… Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MIC B12+L-Carnitine+Chromium injection, Methionine Inositol Choline Methylcobalamin+L-Carnitine+Chromium,… Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Nicotinamide Adenine Dinucleotide, 0.5 mg, injection, 10mL vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Niacinamide injection, 100mg/mL, 5mL vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Myer’s Cocktail, Pyridoxine/Dexpanthenol/Calcium Gluconate/Niacinamide/Vit B6/Vit B1/Leucine/Vit… Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Zinc Sulfate, 5mg/mL injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Folic Acid, Injection, 10 mg/mL, 10mL vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Trim Calm, GABA/Magnesium/Taurine/Theanine, 50mg/50mg/50mg/50mg/ml, 10mL vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Procaine HCl, 2% injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Pyridoxine HCl, 100 mg/mL Injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Leucine/Isoleucine/Valine injection, 10mg/10mg/5mg/mL/mL, 10mL vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Lysine HCl, 100 mg/mL injection, 10ml Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dexpanthenol, 250mg/mL Injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glycyrrhizic Acid, 8mg/mL Injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Zinc Sulfate,10mg/ml injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Folic Acid, 5mg/ml injection, 10ml vial Lack of sterility assurance. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date:… Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall COSOPT Ophthalmic Solution, USP Failed Stability Specifications: out of specification results for opalescence at 7 month stability study. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Levetiracetam Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in… FDA Class I, its most serious class Class IFDA’s class (needs attention)Feb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IStatusTerminatedWhereNationwide
- Medicine recall CIDOFOVIR DIHYDRATE, (Non-Sterile, For Manufacturing Use), 10g CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportMississippithe one state its words name PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereMississippi
- Medicine recall Cardizem CD (diltiazem HCl) capsules, 120 mg Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Cardizem CD (diltiazem HCl) capsules, 180 mg Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Cardizem CD (diltiazem HCl) capsules, 240 mg Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Cardizem CD (diltiazem HCl) capsules, 300 mg Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Diltiazem HCl CD capsules, 360 mg, 90-count bottles Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle Defective Container; complaints of leakage. Class IIIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word, and 4 states named PublishedFeb 20, 2019ClassClass IIIStatusTerminatedWhereNationwide, and Arkansas, Illinois, Kentucky and New York named
- Medicine recall Infants’ Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free,… Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled. Class IIFDA’s classFeb 20, 2019in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 20, 2019ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.